Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

A critical review of the use of carvedilol in ischemic heart disease.

Chen-Scarabelli C, Saravolatz L Jr, Murad Y, Shieh WS, Qureshi W, Di Rezze J, Abrencillo R, Gardin T, Gidwani UK, Saravolatz L, Faggian G, Scarabelli TM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):391-401. doi: 10.2165/11636090-000000000-00000. Review.

PMID:
23061698
[PubMed - indexed for MEDLINE]
2.

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.

Ruffolo RR Jr, Feuerstein GZ.

Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:247-56. Review.

PMID:
9211017
[PubMed - indexed for MEDLINE]
3.

Beta-blockers in heart failure. The 'new wave' of clinical trials.

Krum H.

Drugs. 1999 Aug;58(2):203-10. Review.

PMID:
10473016
[PubMed - indexed for MEDLINE]
4.

Carvedilol: a nonselective beta blocking agent with antioxidant properties.

Book WM.

Congest Heart Fail. 2002 May-Jun;8(3):173-7, 190. Review. Erratum in: Congest Heart Fail 2002 Jul-Aug;8(4):240.

PMID:
12045386
[PubMed - indexed for MEDLINE]
5.

Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.

Kopecky SL.

Am J Cardiol. 2006 Oct 15;98(8):1115-9. Epub 2006 Aug 31. Review.

PMID:
17027583
[PubMed - indexed for MEDLINE]
6.

Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Dunn CJ, Lea AP, Wagstaff AJ.

Drugs. 1997 Jul;54(1):161-85. Review.

PMID:
9211087
[PubMed - indexed for MEDLINE]
7.

[Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].

Vasil'ev AP, Strel'tsova NN, Gorbunova TIu, Mal'tseva IA, Zykova EL.

Ter Arkh. 2001;73(10):65-7. Russian.

PMID:
11763521
[PubMed - indexed for MEDLINE]
8.

Carvedilol in the treatment of chronic heart failure.

Moe G.

Expert Opin Pharmacother. 2001 May;2(5):831-43. Review.

PMID:
11336626
[PubMed - indexed for MEDLINE]
9.

A review of carvedilol arrhythmia data in clinical trials.

Kowey PR.

J Cardiovasc Pharmacol Ther. 2005 Jun;10 Suppl 1:S59-68. Review.

PMID:
15965573
[PubMed - indexed for MEDLINE]
10.

Myocardial autophagy variation during acute myocardial infarction in rats: the effects of carvedilol.

Zhang JL, Lu JK, Chen D, Cai Q, Li TX, Wu LS, Wu XS.

Chin Med J (Engl). 2009 Oct 5;122(19):2372-9.

PMID:
20079142
[PubMed - indexed for MEDLINE]
Free Article
11.

Carvedilol: just another Beta-blocker or a powerful cardioprotector?

Carreira RS, Monteiro P, Gon Alves LM, Providência LA.

Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):257-66. Review.

PMID:
17378771
[PubMed - indexed for MEDLINE]
12.

Carvedilol--clinical experience in arrhythmias.

Storstein L.

Cardiology. 1993;82 Suppl 3:29-33. Review.

PMID:
8106161
[PubMed - indexed for MEDLINE]
13.

Carvedilol: a review of its use in chronic heart failure.

Keating GM, Jarvis B.

Drugs. 2003;63(16):1697-741. Review.

PMID:
12904089
[PubMed - indexed for MEDLINE]
14.

Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.

Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR Jr.

J Hypertens Suppl. 1993 Jun;11(4):S41-8.

PMID:
8104241
[PubMed - indexed for MEDLINE]
15.

Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart.

Kurz T, Richardt D, Görge B, Hartmann F, Tölg R, Katus HA, Richardt G.

J Cardiovasc Pharmacol. 2000 Jul;36(1):96-100.

PMID:
10892666
[PubMed - indexed for MEDLINE]
16.

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.

Feuerstein GZ, Ruffolo RR Jr.

Eur Heart J. 1996 Apr;17 Suppl B:24-9. Review.

PMID:
8733068
[PubMed - indexed for MEDLINE]
Free Article
18.

Cardiac remodeling in coronary artery disease.

Sharpe N.

Am J Cardiol. 2004 May 6;93(9A):17B-20B. Review.

PMID:
15144932
[PubMed - indexed for MEDLINE]
19.

Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.

Okafor CC, Perreault-Micale C, Hajjar RJ, Lebeche D, Skiroman K, Jabbour G, Doye AA, Lee MX, Laste N, Gwathmey JK.

BMC Physiol. 2003 Jul 21;3:6. Epub 2003 Jul 21.

PMID:
12873352
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol.

Feuerstein G, Yue TL, Ma X, Ruffolo RR.

Prog Cardiovasc Dis. 1998 Jul-Aug;41(1 Suppl 1):17-24. Review.

PMID:
9715819
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk